Saudi Chemical’s H1 profit edges up on higher sales

25/07/2018 Argaam Exclusive

View other reports

Saudi Chemical reported a net profit of SAR 84.24 million in the first half of 2018, up 0.61 percent year-on-year (YoY) amid higher sales as a result of an increase in pharmaceutical sales.

Financials (M)

Item	6m 2017	6m 2018	Change‬
Revenues	1,268.96	1,444.96	13.9 %
Gross Income	211.49	215.12	1.7 %
Operating Income	106.40	110.05	3.4 %
Net Income	83.73	84.24	0.6 %
Average Shares	843.20	843.20	-
EPS (Riyals)	0.10	0.10	0.6 %

Net profit declined 2.5 percent to SAR 27.82 million in the second quarter, mainly due to a decline in sales of explosives, which have higher profit margins, as well as an increase in financial charges.

On a sequential basis, net income halved from SAR 56.42 million the previous quarter on account of lower sales due to the stoppage in production of explosives during Ramadan and Eid Al-Fitr. The company also cited higher operating expenses and financial charges.

Current Quarter Comparison (M)

Compared With The

Item	Q2 2017	Q2 2018	Change‬
Revenues	544.28	653.78	20.1 %
Gross Income	93.09	93.63	0.6 %
Operating Income	40.00	38.79	(3.0 %)
Net Income	28.54	27.82	(2.5 %)
Average Shares	843.20	843.20	-
EPS (Riyals)	0.03	0.03	(2.5 %)

Item	Q1 2018	Q2 2018	Change‬
Revenues	791.18	653.78	(17.4 %)
Gross Income	121.48	93.63	(22.9 %)
Operating Income	71.27	38.79	(45.6 %)
Net Income	56.42	27.82	(50.7 %)
Average Shares	843.20	843.20	-
EPS (Riyals)	0.07	0.03	(50.7 %)

Financial results (Million)

Period	Revenues	Change	Gross Income	Change	Net Income	Change	EPS(Riyal)
Q1 2009	422.98	3.9 %	86.46	22.3 %	67.48	100.1 %	0.08
Q2 2009	396.24	7.7 %	86.27	50.7 %	63.76	2.5 %	0.08
Q3 2009	350.64	23.9 %	75.14	24.2 %	104.70	133.2 %	0.12
Q4 2009	473.48	(1.1 %)	98.42	27.2 %	65.10	9.0 %	0.08
2009	1,643.34	6.9 %	346.29	30.3 %	301.03	50.1 %	0.36
Q1 2010	404.20	(4.4 %)	98.12	13.5 %	74.73	10.7 %	0.09
Q2 2010	435.49	9.9 %	106.98	24.0 %	86.47	35.6 %	0.10
Q3 2010	279.73	(20.2 %)	84.51	12.5 %	54.21	(48.2 %)	0.06
Q4 2010	538.90	13.8 %	111.94	13.7 %	87.77	34.8 %	0.10
2010	1,658.32	0.9 %	425.26	22.8 %	303.17	0.7 %	0.36
Q1 2011	469.13	16.1 %	127.36	29.8 %	86.18	15.3 %	0.10
Q2 2011	364.79	(16.2 %)	114.09	6.6 %	76.03	(12.1 %)	0.09
Q3 2011	412.74	47.5 %	86.14	1.9 %	46.73	(13.8 %)	0.06
Q4 2011	620.91	15.2 %	105.82	(5.5 %)	58.46	(33.4 %)	0.07
2011	1,867.57	12.6 %	433.41	1.9 %	267.41	(11.8 %)	0.32
Q1 2012	543.96	16.0 %	125.43	(1.5 %)	87.87	2.0 %	0.10
Q2 2012	464.55	27.3 %	132.00	15.7 %	86.89	14.3 %	0.10
Q3 2012	339.73	(17.7 %)	96.82	12.4 %	50.74	8.6 %	0.06
Q4 2012	653.09	5.2 %	120.26	13.6 %	65.77	12.5 %	0.08
2012	2,001.33	7.2 %	474.51	9.5 %	291.27	8.9 %	0.35
Q1 2013	608.71	11.9 %	118.07	(5.9 %)	88.29	0.5 %	0.10
Q2 2013	561.58	20.9 %	131.45	(0.4 %)	77.19	(11.2 %)	0.09
Q3 2013	412.44	21.4 %	103.64	7.0 %	60.38	19.0 %	0.07
Q4 2013	692.39	6.0 %	130.62	8.6 %	74.75	13.6 %	0.09
2013	2,275.12	13.7 %	479.48	1.0 %	300.60	3.2 %	0.36
Q1 2014	693.05	13.9 %	145.19	23.0 %	90.95	3.0 %	0.11
Q2 2014	651.85	16.1 %	138.73	5.5 %	86.64	12.2 %	0.10
Q3 2014	529.03	28.3 %	99.05	(4.4 %)	39.51	(34.6 %)	0.05
Q4 2014	610.38	(11.8 %)	119.82	(8.3 %)	66.46	(11.1 %)	0.08
2014	2,484.32	9.2 %	502.80	4.9 %	283.56	(5.7 %)	0.34
Q1 2015	678.47	(2.1 %)	139.29	(4.1 %)	86.22	(5.2 %)	0.10
Q2 2015	636.15	(2.4 %)	141.08	1.7 %	78.06	(9.9 %)	0.09
Q3 2015	489.68	(7.4 %)	85.74	(13.4 %)	35.75	(9.5 %)	0.04
Q4 2015	607.57	(0.5 %)	128.97	7.6 %	50.66	(23.8 %)	0.06
2015	2,409.77	(3.0 %)	492.99	(1.9 %)	250.68	(11.6 %)	0.30
Q1 2016	588.45	(13.3 %)	111.67	(19.8 %)	51.52	(40.2 %)	0.06
Q2 2016	617.59	(2.9 %)	114.15	(19.1 %)	47.40	(39.3 %)	0.06
Q3 2016	444.82	(9.2 %)	75.31	(12.2 %)	18.42	(48.5 %)	0.02
Q4 2016	492.21	(19.0 %)	86.44	(33.0 %)	17.09	(66.3 %)	0.02
2016	2,143.06	(11.1 %)	387.57	(21.4 %)	134.43	(46.4 %)	0.16
Q1 2017	724.68	23.2 %	118.40	6.0 %	55.20	7.1 %	0.07
Q2 2017	544.28	(11.9 %)	93.09	(18.5 %)	28.54	(39.8 %)	0.03
Q3 2017	513.16	15.4 %	83.60	11.0 %	27.85	51.2 %	0.03
Q4 2017	692.22	40.6 %	101.23	17.1 %	30.57	78.9 %	0.04
2017	2,474.34	15.5 %	396.31	2.3 %	142.15	5.7 %	0.17
Q1 2018	791.18	9.2 %	121.48	2.6 %	56.42	2.2 %	0.07
Q2 2018	653.78	20.1 %	93.63	0.6 %	27.82	(2.5 %)	0.03

Period	Revenues	Change	Gross Income	Change	Net Income	Change	EPS(Riyal)
2008	1,537.16	25.0 %	265.85	28.8 %	200.53	79.4 %	0.24
2009	1,643.34	6.9 %	346.29	30.3 %	301.03	50.1 %	0.36
2010	1,658.32	0.9 %	425.26	22.8 %	303.17	0.7 %	0.36
2011	1,867.57	12.6 %	433.41	1.9 %	267.41	(11.8 %)	0.32
2012	2,001.33	7.2 %	474.51	9.5 %	291.27	8.9 %	0.35
2013	2,275.12	13.7 %	479.48	1.0 %	300.60	3.2 %	0.36
2014	2,484.32	9.2 %	502.80	4.9 %	283.56	(5.7 %)	0.34
2015	2,409.77	(3.0 %)	492.99	(1.9 %)	250.68	(11.6 %)	0.30
2016	2,143.06	(11.1 %)	387.57	(21.4 %)	134.43	(46.4 %)	0.16
2017	2,474.34	15.5 %	396.31	2.3 %	142.15	5.7 %	0.17

Profitability

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2009	18.13 %	15.06 %	15.09 %
Q2 2009	19.65 %	16.67 %	14.92 %
Q3 2009	19.73 %	16.99 %	17.93 %
Q4 2009	21.07 %	17.70 %	18.32 %
2009	21.07 %	17.70 %	18.32 %
Q1 2010	22.03 %	18.87 %	18.98 %
Q2 2010	22.76 %	19.69 %	19.89 %
Q3 2010	24.36 %	20.28 %	17.54 %
Q4 2010	24.21 %	19.99 %	18.22 %
2010	25.64 %	20.06 %	18.28 %
Q1 2011	25.00 %	19.85 %	18.19 %
Q2 2011	26.50 %	20.18 %	18.34 %
Q3 2011	24.62 %	18.50 %	16.62 %
Q4 2011	23.21 %	17.03 %	14.32 %
2011	23.21 %	17.03 %	14.32 %
Q1 2012	22.21 %	16.52 %	13.85 %
Q2 2012	22.01 %	16.23 %	13.71 %
Q3 2012	23.36 %	17.22 %	14.42 %
Q4 2012	23.71 %	17.12 %	14.55 %
2012	23.71 %	17.12 %	14.55 %
Q1 2013	22.61 %	15.90 %	13.37 %
Q2 2013	21.57 %	14.90 %	12.32 %
Q3 2013	21.17 %	14.59 %	12.35 %
Q4 2013	21.26 %	14.70 %	12.53 %
2013	21.07 %	14.69 %	12.53 %
Q1 2014	21.65 %	14.94 %	12.85 %
Q2 2014	21.15 %	14.60 %	12.68 %
Q3 2014	20.01 %	13.27 %	11.29 %
Q4 2014	20.24 %	13.37 %	11.33 %
2014	20.24 %	13.37 %	11.33 %
Q1 2015	20.12 %	13.27 %	11.21 %
Q2 2015	20.34 %	13.11 %	11.01 %
Q3 2015	20.12 %	13.05 %	11.04 %
Q4 2015	20.53 %	12.70 %	10.39 %
2015	20.46 %	12.63 %	10.40 %
Q1 2016	20.13 %	11.88 %	9.30 %
Q2 2016	19.13 %	10.76 %	8.05 %
Q3 2016	19.04 %	10.39 %	7.44 %
Q4 2016	18.08 %	10.13 %	6.76 %
2016	18.08 %	10.13 %	6.76 %
Q1 2017	17.30 %	9.71 %	6.51 %
Q2 2017	16.92 %	9.17 %	5.87 %
Q3 2017	16.78 %	9.17 %	6.11 %
Q4 2017	16.02 %	8.52 %	5.74 %
2017	16.02 %	8.52 %	5.74 %
Q1 2018	15.72 %	8.50 %	5.64 %
Q2 2018	15.09 %	8.20 %	5.38 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
2008	17.29 %	14.64 %	13.05 %
2009	21.07 %	17.70 %	18.32 %
2010	25.64 %	20.06 %	18.28 %
2011	23.21 %	17.03 %	14.32 %
2012	23.71 %	17.12 %	14.55 %
2013	21.07 %	14.69 %	12.53 %
2014	20.24 %	13.37 %	11.33 %
2015	20.46 %	12.63 %	10.40 %
2016	18.08 %	10.13 %	6.76 %
2017	16.02 %	8.52 %	5.74 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2009	20.44 %	16.52 %	15.95 %
Q2 2009	21.77 %	19.37 %	16.09 %
Q3 2009	21.43 %	18.97 %	29.86 %
Q4 2009	20.79 %	16.42 %	13.75 %
Q1 2010	24.28 %	21.14 %	18.49 %
Q2 2010	24.57 %	22.48 %	19.85 %
Q3 2010	30.21 %	22.16 %	18.99 %
Q4 2010	20.77 %	16.00 %	16.29 %
Q1 2011	27.15 %	20.47 %	18.37 %
Q2 2011	31.28 %	24.46 %	20.84 %
Q3 2011	20.87 %	14.27 %	11.32 %
Q4 2011	17.04 %	11.91 %	9.41 %
Q1 2012	23.06 %	18.16 %	16.15 %
Q2 2012	28.41 %	21.49 %	18.70 %
Q3 2012	28.50 %	19.58 %	14.94 %
Q4 2012	18.41 %	11.85 %	10.07 %
Q1 2013	19.40 %	13.92 %	11.97 %
Q2 2013	23.41 %	16.66 %	13.73 %
Q3 2013	25.13 %	17.12 %	14.64 %
Q4 2013	18.87 %	12.36 %	10.80 %
Q1 2014	20.95 %	14.83 %	13.12 %
Q2 2014	21.28 %	15.15 %	12.98 %
Q3 2014	18.72 %	10.12 %	7.47 %
Q4 2014	19.63 %	12.64 %	10.89 %
Q1 2015	20.53 %	14.51 %	12.71 %
Q2 2015	22.18 %	14.55 %	12.27 %
Q3 2015	17.51 %	9.58 %	7.30 %
Q4 2015	21.23 %	11.27 %	8.34 %
Q1 2016	18.98 %	11.55 %	8.76 %
Q2 2016	18.48 %	10.44 %	7.67 %
Q3 2016	16.93 %	7.59 %	4.14 %
Q4 2016	17.56 %	10.33 %	5.57 %
Q1 2017	16.34 %	9.97 %	7.62 %
Q2 2017	17.10 %	8.34 %	5.24 %
Q3 2017	16.29 %	7.83 %	5.43 %
Q4 2017	14.62 %	7.66 %	4.42 %
Q1 2018	15.35 %	9.78 %	7.13 %
Q2 2018	14.32 %	7.14 %	4.26 %

Per Share Data (Riyal)

Compared With The

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
Q1 2009	843.20	0.28	0.28	1.38
Q2 2009	843.20	0.28	0.28	1.46
Q3 2009	843.20	0.35	0.35	1.58
Q4 2009	843.20	0.36	0.36	1.47
Q1 2010	843.20	0.37	0.37	1.56
Q2 2010	843.20	0.39	0.39	1.55
Q3 2010	843.20	0.33	0.33	1.61
Q4 2010	843.20	0.36	0.36	1.60
Q1 2011	843.20	0.37	0.37	1.71
Q2 2011	843.20	0.36	0.36	1.65
Q3 2011	843.20	0.35	0.35	1.70
Q4 2011	843.20	0.32	0.32	1.62
Q1 2012	843.20	0.32	0.32	1.73
Q2 2012	843.20	0.33	0.33	1.72
Q3 2012	843.20	0.34	0.34	1.78
Q4 2012	843.20	0.35	0.35	1.69
Q1 2013	843.20	0.35	0.33	1.79
Q2 2013	843.20	0.33	0.32	1.77
Q3 2013	843.20	0.35	0.33	1.84
Q4 2013	843.20	0.36	0.34	1.78
Q1 2014	843.20	0.36	0.36	1.89
Q2 2014	843.20	0.37	0.37	1.86
Q3 2014	843.20	0.35	0.34	1.90
Q4 2014	843.20	0.34	0.33	1.83
Q1 2015	843.20	0.33	0.33	1.93
Q2 2015	843.20	0.32	0.32	1.80
Q3 2015	843.20	0.32	0.32	1.84
Q4 2015	843.20	0.30	0.30	1.90
Q1 2016	843.20	0.26	0.26	1.75
Q2 2016	843.20	0.22	0.22	1.81
Q3 2016	843.20	0.20	0.20	1.83
Q4 2016	843.20	0.16	0.17	1.74
Q1 2017	843.20	0.16	0.18	1.81
Q2 2017	843.20	0.14	0.15	1.76
Q3 2017	843.20	0.15	0.16	1.80
Q4 2017	843.20	0.17	0.17	1.76
Q1 2018	843.20	0.17	0.17	1.83
Q2 2018	843.20	0.17	0.17	1.86

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
2008	843.20	0.24	0.24	1.30
2009	843.20	0.36	0.36	1.47
2010	843.20	0.36	0.36	1.60
2011	843.20	0.32	0.32	1.62
2012	843.20	0.35	0.35	1.69
2013	843.20	0.36	0.34	1.78
2014	843.20	0.34	0.33	1.83
2015	843.20	0.30	0.30	1.90
2016	843.20	0.16	0.17	1.74
2017	843.20	0.17	0.17	1.76

Multiple Ratios (End of Period Price)

Compared With The

Period	P/E	Adjusted P/E	Price/book
Q1 2009	5.84	5.84	1.18
Q2 2009	7.48	7.48	1.44
Q3 2009	6.74	6.74	1.50
Q4 2009	8.70	8.70	2.11
Q1 2010	8.80	8.80	2.06
Q2 2010	7.78	7.78	1.97
Q3 2010	10.75	10.80	2.22
Q4 2010	8.68	8.71	1.94
Q1 2011	9.09	9.12	1.99
Q2 2011	9.50	9.54	2.08
Q3 2011	8.76	8.76	1.81
Q4 2011	9.29	9.29	1.82
Q1 2012	9.71	9.71	1.79
Q2 2012	8.67	8.67	1.68
Q3 2012	8.69	8.69	1.65
Q4 2012	9.71	9.71	1.99
Q1 2013	9.19	9.71	1.78
Q2 2013	10.32	10.92	1.95
Q3 2013	10.32	10.90	1.94
Q4 2013	11.57	12.20	2.32
Q1 2014	12.72	12.72	2.42
Q2 2014	14.29	14.38	2.85
Q3 2014	16.47	16.59	2.99
Q4 2014	12.77	12.86	2.35
Q1 2015	15.68	15.79	2.68
Q2 2015	17.04	17.04	3.03
Q3 2015	14.78	14.78	2.53
Q4 2015	14.46	14.46	2.27
Q1 2016	13.72	13.72	2.00
Q2 2016	14.53	14.53	1.76
Q3 2016	11.77	11.77	1.28
Q4 2016	18.32	17.01	1.68
Q1 2017	15.42	14.35	1.40
Q2 2017	20.31	18.69	1.63
Q3 2017	17.20	15.92	1.46
Q4 2017	14.29	14.29	1.37
Q1 2018	14.60	14.60	1.36
Q2 2018	15.80	15.80	1.44

Period	P/E	Adjusted P/E	Price/book
2008	6.61	6.61	1.21
2009	8.70	8.70	2.11
2010	8.68	8.68	1.94
2011	9.29	9.29	1.82
2012	9.71	9.71	1.99
2013	11.57	12.20	2.32
2014	12.77	12.86	2.35
2015	14.46	14.46	2.27
2016	18.32	17.01	1.68
2017	14.29	14.29	1.37

Business Segments (Million)

Compared With The

Period	Medicines and medical supplies	Explosives sector	Production of ammonium nitrate
Q1 2009	351.39	71.60	-
Q2 2009	327.68	68.57	-
Q3 2009	282.02	68.62	-
Q4 2009	394.61	78.87	-
Q1 2010	313.46	76.69	14.06
Q2 2010	329.91	91.05	14.52
Q3 2010	197.06	74.39	8.29
Q4 2010	458.47	71.57	8.86
Q1 2011	368.14	99.55	1.43
Q2 2011	269.28	95.51	-
Q3 2011	334.61	76.50	1.63
Q4 2011	532.27	86.84	1.81
Q1 2012	441.68	102.29	-
Q2 2012	347.97	115.14	1.43
Q3 2012	249.03	90.71	-
Q4 2012	560.94	90.71	1.44
Q1 2013	504.23	99.55	4.94
Q2 2013	454.26	110.50	(3.18)
Q3 2013	305.21	107.23	-
Q4 2013	595.40	97.00	-
Q1 2014	577.21	115.84	-
Q2 2014	513.14	138.71	-
Q3 2014	434.89	91.56	2.58
Q4 2014	500.81	108.14	1.44
Q1 2015	560.46	115.12	2.89
Q2 2015	519.48	113.30	3.37
Q3 2015	407.09	77.87	2.63
Q4 2015	495.40	108.75	3.42
Q1 2016	486.51	100.15	1.79
Q2 2016	523.71	92.30	1.58
Q3 2016	380.20	67.99	-
Q4 2016	401.59	84.23	6.39
Q1 2017	642.39	81.80	0.49
Q2 2017	461.84	80.81	1.63
Q3 2017	439.71	69.84	3.61
Q4 2017	601.78	86.92	3.52
Q1 2018	709.39	79.68	2.11
Q2 2018	593.51	58.30	1.97

Period	Medicines and medical supplies	Explosives sector	Production of ammonium nitrate
2008	1,293.81	243.35	-
2009	1,355.69	287.65	-
2010	1,298.90	313.69	45.73
2011	1,504.30	358.40	4.88
2012	1,599.61	398.85	2.87
2013	1,859.09	414.27	1.76
2014	2,026.05	454.25	4.02
2015	1,982.43	415.03	12.31
2016	1,792.00	344.67	6.39
2017	2,145.72	319.37	9.25

Financial Ratios

	Current
Market Cap (M Riyal)	9,292.06
Enterprise Value (EV) (M)	10,601.97
Shares Outstanding ((M))	843.20
EPS ( Riyal) (TTM)	0.29
Book Value (BV) ( Riyal)	2.24
Par Value ( Riyal)	1.00
Adjusted P/E (Last12)	38.39
P/E (TTM)	38.39
Price/book	4.91
Return on Average Assets (%) (TTM)	4.6
Return on Average Equity (%) (TTM)	13.5

Saudi Chemical Co. (CHEMICAL)

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Sign In

Search Result

Saudi Chemical’s H1 profit edges up on higher sales

View other reports

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million)

Revenue by Business Segment (Latest) 2018 Q2

Financial Ratios

Share Price

Saudi Chemical Co. (CHEMICAL)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Sign In

×

Forgot password?

Saudi Chemical’s H1 profit edges up on higher sales

View other reports

Financials (M)

Current Quarter Comparison (M)

Financial results (Million)

Financial results (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million) Q2 2018

Revenue by Business Segment (Latest) 2018 Q2

Financial Ratios

Share Price

Saudi Chemical Co. (CHEMICAL)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Business Segments (Million)